The crucial role of cutting-edge biomaterials and biomarkers in revolutionizing cancer treatment lies in their ability to enhance precision and effectiveness in various therapeutic approaches. This field focuses on developing advanced biomaterials such as nanocarriers, hydrogels, and biodegradable polymers that enhance targeted drug delivery, tissue engineering, and localized therapy. Additionally, biomarkers are integral for early cancer detection, guiding precision medicine, and improving immunotherapy outcomes. The integration of technologies like 3D bioprinting and wearable biosensors offers promising advancements in tumor modeling, personalized treatment, and real-time monitoring. Overall, the advanced biomaterials and biomarker technologies underscores the significant impact of these innovations in enhancing cancer diagnosis and therapeutic strategies.

Potential topics include but are not limited to:

-Smart nanocarriers for precision oncology: biomaterial-based approaches

-Advances in biomarker-guided immunotherapy for cancer treatment

-Biodegradable nanoparticles in chemotherapy for sustained drug release

-Biomaterial scaffolds for tumor microenvironment modulation

-Exosome-derived biomarkers: new frontiers in cancer diagnosis

-Hydrogel-based drug delivery systems for targeted cancer therapy

-Wearable biosensors for real-time monitoring of cancer biomarkers

-Biomaterials in radiotherapy: enhancing targeted treatment of cancer cells

Author registration and submission: https://accscience.com/user/login. Submit your paper along with a cover letter, including the special issue title. Your paper will undergo a fair peer review and be published immediately after acceptance and will be available to an international audience.